Related Experiment Video
Updated: Mar 7, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
New and Unexpected Biological Functions for the Src-Homology 2 Domain-Containing Phosphatase SHP-2 in the
Geneviève Coulombe1, Nathalie Rivard1
1Department of Anatomy and Cell Biology, Cancer Research Pavilion, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
Abstract:
SHP-2 is a tyrosine phosphatase expressed in most embryonic and adult tissues. SHP-2 regulates many cellular functions including growth, differentiation, migration, and survival. Genetic and biochemical evidence show that SHP-2 is required for rat sarcoma viral oncogene/extracellular signal-regulated kinases mitogen-activated protein kinase pathway activation by most tyrosine kinase receptors, as well as by G-protein-coupled and cytokine receptors. In addition, SHP-2 can regulate the Janus kinase/signal transducers and activators of transcription, nuclear factor-κB, phosphatidyl-inositol 3-kinase/Akt, RhoA, Hippo, and Wnt/β-catenin signaling pathways. Emerging evidence has shown that SHP-2 dysfunction represents a key factor in the pathogenesis of gastrointestinal diseases, in particular in chronic inflammation and cancer. Variations within the gene locus encoding SHP-2 have been associated with increased susceptibility to develop ulcerative colitis and gastric atrophy. Furthermore, mice with conditional deletion of SHP-2 in intestinal epithelial cells rapidly develop severe colitis. Similarly, hepatocyte-specific deletion of SHP-2 induces hepatic inflammation, resulting in regenerative hyperplasia and development of tumors in aged mice. However, the SHP-2 gene initially was suggested to be a proto-oncogene because activating mutations of this gene were found in pediatric leukemias and certain forms of liver and colon cancers. Moreover, SHP-2 expression is up-regulated in gastric and hepatocellular cancers. Notably, SHP-2 functions downstream of cytotoxin-associated antigen A (CagA), the major virulence factor of Helicobacter pylori, and is associated with increased risks of gastric cancer. Further compounding this complexity, most recent findings suggest that SHP-2 also coordinates carbohydrate, lipid, and bile acid synthesis in the liver and pancreas. This review aims to summarize current knowledge and recent data regarding the biological functions of SHP-2 in the gastrointestinal tract.
Insights
SHP-2 phosphatase plays a critical role in gastrointestinal diseases, including inflammation and cancer. Its dysfunction is linked to conditions like ulcerative colitis and gastric cancer, highlighting its importance in GI health.
Area of Science:
- Biochemistry
- Molecular Biology
- Gastroenterology
Background:
- SHP-2 is a tyrosine phosphatase involved in numerous cellular processes like growth, differentiation, migration, and survival.
- It regulates key signaling pathways including MAPK, JAK/STAT, NF-κB, PI3K/Akt, and Wnt/β-catenin.
- SHP-2 dysfunction is increasingly recognized as a significant factor in gastrointestinal disease pathogenesis.
Purpose of the Study:
- To review the biological functions of SHP-2 in the gastrointestinal tract.
- To summarize current knowledge and recent data on SHP-2's role in GI health and disease.
- To highlight SHP-2's involvement in gastrointestinal inflammation and cancer.
Main Methods:
- Literature review of genetic and biochemical evidence.
- Analysis of studies on SHP-2's role in various signaling pathways.
- Examination of data from mouse models with conditional SHP-2 deletion.
- Review of clinical associations between SHP-2 variations and GI diseases.
Main Results:
- SHP-2 is essential for MAPK pathway activation by multiple receptor types.
- SHP-2 dysfunction is linked to increased susceptibility to ulcerative colitis and gastric atrophy.
- Conditional deletion of SHP-2 in mice leads to severe colitis and liver tumors.
- SHP-2 mutations are associated with pediatric leukemias and certain cancers; its expression is upregulated in gastric and liver cancers.
- SHP-2 functions downstream of *Helicobacter pylori*'s CagA, increasing gastric cancer risk.
Conclusions:
- SHP-2 is a critical regulator of gastrointestinal cellular functions and signaling.
- SHP-2 dysfunction is implicated in the development and progression of gastrointestinal inflammatory diseases and cancers.
- Further research into SHP-2's multifaceted roles is crucial for understanding and treating GI disorders.
Related Concept Videos
The JAK-STAT Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
Hedgehog Signaling Pathway

